Coats' disease associated with muscular dystrophy treated with ranibizumab.
Diago
T
T
Valls
B
B
Pulido
J S
JS
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000150:complications*; D000069579:Ranibizumab; D012160:Retina / Q000473:pathology; D058456:Retinal Telangiectasis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome; D014792:Visual Acuity
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069579:Ranibizumab